XML 24 R3.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Current assets:                  
Cash and cash equivalents $ 221,755       $ 113,006        
Marketable securities 0       67,321        
Prepaid expenses 14,800       8,618        
Inventory 22,919       0        
Receivables and other current assets 22,211       14,627        
Total current assets 281,685       203,572        
Marketable securities 0       1,414        
Property, plant and equipment, net 65,936       67,636        
Intangible assets, net 10,438       4,868        
Goodwill 5,646       5,646        
Operating lease right-of-use assets 201,113       230,885        
Restricted cash and other non-current assets 54,343       55,793        
Total assets 619,161       569,814        
Current liabilities:                  
Accounts payable 18,498       14,867        
Due to factor 2,520       0        
Accrued expenses and other current liabilities 73,188       53,464        
Operating lease liability, current portion 21,202       27,594        
Finance lease liability, current portion 84,705       60,654        
Total current liabilities 200,113       156,579        
Operating lease liability, net of current portion 186,687       209,128        
Finance lease liability, net of current portion 37,732       69,682        
Other non-current liabilities 92       92        
Total liabilities 424,624       435,481        
Commitments and contingencies Note 12              
Stockholders' equity:                  
Preferred stock, $0.01 par value, 5,000 shares authorized; 0 shares issued and    outstanding at December 31, 2023 and December 31, 2022 0       0        
Common stock, $0.01 par value, 250,000 and 125,000 shares authorized; 192,772 and 82,923 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively 1,905       830        
Additional paid-in capital 4,454,756       4,185,988        
Accumulated other comprehensive loss (1,796)       (4,070)        
Accumulated deficit (4,260,328)       (4,048,415)        
Total stockholders' equity 194,537       134,333       $ 276,129
Total liabilities and stockholders' equity $ 619,161       $ 569,814        
Common stock, shares authorized (in shares) 250,000,000 250,000,000 250,000,000 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000